Display options
Cite
Milione M, Ardini E, Christiansen J, et al. Identification and characterization of a novel . Oncotarget. 2017;8(33):55353-55360doi: 10.18632/oncotarget.19512.
Milione, M., Ardini, E., Christiansen, J., Valtorta, E., Veronese, S., Bosotti, R., Pellegrinelli, A., Testi, A., Pietrantonio, F., Fucà, G., Wei, G., Murphy, D., Siena, S., Isacchi, A., & De Braud, F. (2017). Identification and characterization of a novel . Oncotarget, 8(33), 55353-55360. https://doi.org/10.18632/oncotarget.19512
Milione, Massimo, et al. "Identification and characterization of a novel ." Oncotarget vol. 8,33 (2017): 55353-55360. doi: https://doi.org/10.18632/oncotarget.19512
Milione M, Ardini E, Christiansen J, Valtorta E, Veronese S, Bosotti R, Pellegrinelli A, Testi A, Pietrantonio F, Fucà G, Wei G, Murphy D, Siena S, Isacchi A, De Braud F. Identification and characterization of a novel . Oncotarget. 2017 Jul 24;8(33):55353-55360. doi: 10.18632/oncotarget.19512. eCollection 2017 Aug 15. PMID: 28903424; PMCID: PMC5589663.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Jul 24;8(33):55353-55360. doi: 10.18632/oncotarget.19512. eCollection 2017 Aug 15.

Identification and characterization of a novel .

Oncotarget

Massimo Milione, Elena Ardini, Jason Christiansen, Emanuele Valtorta, Silvio Veronese, Roberta Bosotti, Alessio Pellegrinelli, Adele Testi, Filippo Pietrantonio, Giovanni Fucà, Ge Wei, Danielle Murphy, Salvatore Siena, Antonella Isacchi, Filippo De Braud

Affiliations

  1. 1st Division of Pathology, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  2. Nerviano Medical Sciences S.r.l., Milan, Italy.
  3. Ignyta, Inc., San Diego, CA, United States of America.
  4. Division of Pathology, Department of Laboratory Medicine, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  5. Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano, Milan, Italy.
  6. Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

PMID: 28903424 PMCID: PMC5589663 DOI: 10.18632/oncotarget.19512

Abstract

In colorectal cancer patients, chromosomal rearrangements involving

Keywords: CRC; NTRK1; TRKA; entrectinib; rearrangement

Conflict of interest statement

CONFLICTS OF INTEREST The authors have no potential conflicts of interest to declare

References

  1. Curr Opin Oncol. 2007 Jan;19(1):55-60 - PubMed
  2. Exp Cell Res. 2003 Apr 1;284(2):224-38 - PubMed
  3. Oncotarget. 2015 Nov 17;6(36):39028-35 - PubMed
  4. Mol Oncol. 2014 Dec;8(8):1495-507 - PubMed
  5. Tumori. 2016 Dec 1;102(6):541-547 - PubMed
  6. Eur J Cancer. 2015 Mar;51(5):587-94 - PubMed
  7. Lancet Oncol. 2016 Jun;17 (6):738-746 - PubMed
  8. Ann Oncol. 2014 Feb;25(2):404-8 - PubMed
  9. Lancet. 2016 Sep 3;388(10048):1012-24 - PubMed
  10. J Natl Cancer Inst. 2015 Nov 12;108(1):null - PubMed
  11. Nat Med. 2013 Nov;19(11):1469-1472 - PubMed
  12. Clin Cancer Res. 2012 Dec 15;18(24):6599-608 - PubMed
  13. PLoS One. 2014 Mar 19;9(3):e91940 - PubMed
  14. Cancer Discov. 2017 Apr;7(4):400-409 - PubMed
  15. Mol Cell Endocrinol. 2010 May 28;321(1):44-9 - PubMed
  16. Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):513-523 - PubMed
  17. Ther Adv Med Oncol. 2016 Jul;8(4):276-93 - PubMed
  18. Cancer Lett. 2015 Aug 28;365(1):107-11 - PubMed
  19. Mol Cancer Ther. 2016 Apr;15(4):628-39 - PubMed
  20. Crit Rev Oncol Hematol. 2015 Oct;96(1):156-66 - PubMed
  21. Oncotarget. 2016 Feb 16;7(7):8399-412 - PubMed
  22. Cancer Discov. 2016 Sep;6(9):963-71 - PubMed
  23. Oncol Res Treat. 2016;39(12 ):796-802 - PubMed
  24. N Engl J Med. 2015 Jun 25;372(26):2509-20 - PubMed
  25. Clin Cancer Res. 2015 May 15;21(10):2227-35 - PubMed
  26. ESMO Open. 2016 Mar 18;1(2):e000023 - PubMed

Publication Types